Plus, stimulus negotiations are still going, Pfizer said it has set up its “biggest ever” logistics operation to distribute its COVID-19 vaccine candidate, and Nikola shares are up on hopes for its deal with GM.
Read MorePlus, today is do-or-die day for a stimulus deal before the election, Moderna’s CEO said it could have emergency use authorization from the FDA in December, and GM announced a $2.2 billion investment in manufacturing electric vehicles.
Read MorePlus, ConocoPhillips is buying Concho Resources, AMC shares are up after New York Gov. Cuomo says movie theaters in the state can reopen, and an analyst issued a prediction for presales for Apple’s new iPhone 12.
Read MoreBuy Price: $5.00 or better Sell Price: TradersPro Sell Signal The stocks founds in the One Hot Stock category use stocks that are in long term, short term trends and are early in the buy signal trend. It is a confirmation strategy that waits for the stock to make a move then a trader enters […]
Read MoreIf you could put your money into just 5 stocks to hold for the next 10 years, which stocks would you choose? Reddit users discussed their top picks this week. Here’s what they said.
Read MorePlus, the tussle over a stimulus deal continues, Morgan Stanley delivered an earnings beat, and Fastly shares plummet after delivering downbeat third-quarter guidance.
Read MoreBuy Price: $123.00 or better Sell Price: TradersPro Sell Signal Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company’s lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that […]
Read MorePlus, earnings results weren’t so good for Bank of America and Wells Fargo, stimulus is looking evermore unlikely prior to the election, and Apple unveiled its newest iPhones.
Read MoreEver since coronavirus found its way to American shores, a large amount of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in […]
Read MoreBuy Price: $40.00 or better Sell Price: TradersPro Sell Signal NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, as well as laboratories in Switzerland and Singapore. It operates in two segments, Clinical Services and Pharma Services. The company’s laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, […]
Read MorePlus, Trump is back at the White House, House Speaker Pelosi and Treasury Secretary Mnuchin will resume stimulus negotiations today, and Apple announced a new product launch event for October 13 where it is expected to unveil new iPhone models.
Read MorePlus, AMC shares are down as movie theaters close with no big releases until the end of this year, Bristol-Myers Squibb is buying MyoKardia, and Nvidia is building a $52 million supercomputer for Cambridge.
Read MorePlus, initial jobless claims were lower than expected, AstraZeneca shares are down after the FDA said it’s expanding its inquiry into the serious illness of a participant in its COVID vaccine trial, and the CEOs of Facebook, Google, and Twitter will be subpoenaed for testimony by the Senate Commerce Committee.
Read MoreBuy Price: $12.50 or better Sell Price: TradersPro Sell Signal Sorrento Therapeutics, Inc., a clinical stage biopharma company, develops therapies for cancer, autoimmune, inflammatory, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric […]
Read MorePlus, several blue-chip companies announced tens of thousands of job cuts, Moderna and Regeneron are up on positive coronavirus drug news, and two software companies went public through direct listings this morning.
Read More